Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysiss
Article in Heliyon (April 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Heliyon (April 2024)
Article in Nature (September 2021)
Article in OncoTargets and Therapy (April 2021)